Hims & Hers Health (NYSE:HIMS – Get Free Report) and Outset Medical (NASDAQ:OM – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations and institutional ownership.
Profitability
This table compares Hims & Hers Health and Outset Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Hims & Hers Health | 6.05% | 24.67% | 9.37% |
| Outset Medical | -73.12% | -71.37% | -30.11% |
Analyst Ratings
This is a summary of recent ratings and price targets for Hims & Hers Health and Outset Medical, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Hims & Hers Health | 3 | 10 | 3 | 1 | 2.12 |
| Outset Medical | 1 | 1 | 2 | 1 | 2.60 |
Valuation & Earnings
This table compares Hims & Hers Health and Outset Medical”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Hims & Hers Health | $1.48 billion | 5.00 | $126.04 million | $0.54 | 60.09 |
| Outset Medical | $113.69 million | 0.59 | -$127.98 million | ($13.05) | -0.28 |
Hims & Hers Health has higher revenue and earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Hims & Hers Health has a beta of 2.37, indicating that its share price is 137% more volatile than the S&P 500. Comparatively, Outset Medical has a beta of 2.07, indicating that its share price is 107% more volatile than the S&P 500.
Insider and Institutional Ownership
63.5% of Hims & Hers Health shares are held by institutional investors. 13.7% of Hims & Hers Health shares are held by company insiders. Comparatively, 2.4% of Outset Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Hims & Hers Health beats Outset Medical on 12 of the 14 factors compared between the two stocks.
About Hims & Hers Health
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
About Outset Medical
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.
